Abbott Directed to Provide Prescribing Details for Triamcinolone Hexacetonide Pre-Filled Syringe
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has instructed Abbott Healthcare Pvt. to submit proposed prescribing information and supporting data for Triamcinolone Hexacetonide Injectable Suspension USP 40 mg/2 ml (Pre-filled syringe).
The directive follows a detailed review of the company's proposal during the SEC meeting on September 17, 2025, at CDSCO headquarters in New Delhi. Abbott presented its proposal for introducing Triamcinolone Hexacetonide Injectable Suspension USP 40 mg/2 ml Pre-filled Syringe for use in already approved indications, along with a justification for the new presentation.
The firm submitted a detailed justification of the rationale and clinical need for this new pre-filled syringe presentation of the drug.
Autor: The company must provide prescribing details.
More News
- The 400 million reasons behind Cricket Australia’s Big Bash sale
- Kate Hudson and Son Ryder Coordinate in Paris
- Babar Azam, Mohammad Rizwan in focus: PCB clears Big Bash NOCs for Pakistan players
- Luke Premieres New Song 'Giving Her Away'
- Katy Perry en couple avec Justine Trudeau : l’ex-Premier ministre la regarde
- Women's Big Bash League: Brisbane Heat's Winless Season Ends With 7-Wicket Loss Against Perth Scorchers
- [Odds on Lando Norris winning SPOTY 2026 tumble as F1 world champion battles Luke Littler and Rory McIlroy for BBC award]
- Hockey30 | Le Mouton Noir du Hockey
- Ryder — Founder and Leader of the PAW Patrol Team
- [Transaction majeure pour un top-6 : c'est confirmé pour trois nom chez le Canadien]